195 related articles for article (PubMed ID: 28078618)
1. Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.
Mezzomo LC; Pesce FG; Marçal JM; Haag T; Ferreira NP; Lima JF; Leães CG; Oliveira MC; da Fonte Kohek MB
Endocr Pathol; 2017 Mar; 28(1):13-21. PubMed ID: 28078618
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas.
Lu R; Gao H; Wang H; Cao L; Bai J; Zhang Y
Oncol Lett; 2013 Mar; 5(3):845-851. PubMed ID: 23426998
[TBL] [Abstract][Full Text] [Related]
3. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Lampichler K; Ferrer P; Vila G; Lutz MI; Wolf F; Knosp E; Wagner L; Luger A; Baumgartner-Parzer S
Endocr Relat Cancer; 2015 Oct; 22(5):793-803. PubMed ID: 26219678
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Notch3 receptor in non-functioning pituitary tumours.
Miao Z; Miao Y; Lin Y; Lu X
J Clin Neurosci; 2012 Jan; 19(1):107-10. PubMed ID: 22153798
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of the Hedgehog signaling pathway in pituitary adenomas.
Yavropoulou MP; Maladaki A; Topouridou K; Kotoula V; Poulios C; Daskalaki E; Foroglou N; Karkavelas G; Yovos JG
Neurosci Lett; 2016 Jan; 611():94-100. PubMed ID: 26620835
[TBL] [Abstract][Full Text] [Related]
7. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
9. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
10. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
[TBL] [Abstract][Full Text] [Related]
11. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
Abbass SA; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
[TBL] [Abstract][Full Text] [Related]
14. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
[TBL] [Abstract][Full Text] [Related]
15. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
16. Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential.
Xu B; Sano T; Yamada S; Li CC; Hirokawa M
J Clin Endocrinol Metab; 2000 Mar; 85(3):1220-5. PubMed ID: 10720066
[TBL] [Abstract][Full Text] [Related]
17. Urocortin expression in human pituitary gland and pituitary adenoma.
Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.
LeRiche VK; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1996 Feb; 81(2):656-62. PubMed ID: 8636285
[TBL] [Abstract][Full Text] [Related]
19. Expression of Neuropeptide Y and Its Relationship with Molecular and Morphological Changes in Human Pituitary Adenomas.
Jia R; Li M; Chang B; Chen L; Ma J
Cancer Biother Radiopharm; 2015 Dec; 30(10):411-9. PubMed ID: 26683132
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.
Zafar M; Ezzat S; Ramyar L; Pan N; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
